Carl Zeiss Meditec AG (ETR:AFX)
Germany · Delayed Price · Currency is EUR 30.44
+0.62 (2.08%)
Aug 13, 2026, 5:35 PM CET
Carl Zeiss Meditec AG Financials Overview
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 2,181 | 2,228 | 2,066 | 2,089 | 1,903 | 1,647 |
Revenue Growth | 0.07% | 7.82% | -1.11% | 9.80% | 15.55% | 23.31% |
Gross Profit Gross Profit Growth | 1,124 | 1,175 | 1,089 | 1,206 | 1,128 | 967.21 |
Operating Income Operating Income Growth | 157.63 | 223.32 | 194.45 | 348.12 | 396.88 | 373.61 |
Net Income Net Income Growth | 121.51 | 141.21 | 178.73 | 290.4 | 293.91 | 236.28 |
Earnings Per Share EPS Growth | 1.38 | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 |
EPS Growth | -19.30% | -19.90% | -38.15% | -1.22% | 24.62% | 92.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Ophthalmology Ophthalmology Growth | 1,669 | 1,724 | 1,589 | 1,576 | 1,469 | 1,256 |
Microsurgery Microsurgery Growth | 498.88 | 503.94 | 476.96 | 512.81 | 433.57 | 391.07 |
Revenue (Total) Revenue (Total) Growth | 2,168 | 2,228 | 2,066 | 2,089 | 1,903 | 1,647 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 23.9 | 27.27 | 20.29 | 10.6 | 7.73 | 7.44 |
Total Debt Total Debt Growth | 617.56 | 607.37 | 629.35 | 275.91 | 286.55 | 252.71 |
Net Cash (Debt) Net Cash Growth | -593.66 | -580.1 | -609.07 | -265.31 | -278.83 | -245.27 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.78 | -6.63 | -6.85 | -2.97 | -3.12 | -2.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 300.27 | 209.86 | 247.32 | 250.86 | 188.2 | 362.66 |
Capital Expenditures CapEx Growth | -27.76 | -39.39 | -86.81 | -65.65 | -42.8 | -30.12 |
Free Cash Flow Free Cash Flow Growth | 272.51 | 170.46 | 160.51 | 185.21 | 145.4 | 332.54 |
Free Cash Flow Growth | 101.39% | 6.21% | -13.34% | 27.38% | -56.28% | 122.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 51.55% | 52.76% | 52.69% | 57.71% | 59.26% | 58.73% |
Operating Margin | 7.23% | 10.02% | 9.41% | 16.66% | 20.86% | 22.69% |
Pretax Margin | 7.19% | 8.70% | 11.66% | 19.75% | 21.20% | 20.59% |
Profit Margin | 5.52% | 6.39% | 8.72% | 13.98% | 15.55% | 14.42% |
FCF Margin | 0.00% | 7.65% | 7.77% | 8.86% | 7.64% | 20.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.550 | 0.550 | 0.600 | 1.100 | 1.100 | 0.900 |
Dividend Per Share Growth | -8.33% | -8.33% | -45.45% | 0% | 22.22% | 80.00% |
Dividend Yield | 1.84% | 1.42% | 1.55% | 1.33% | 0.84% | 0.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 21.83 | 26.19 | 35.40 | 25.48 | 32.66 | 62.90 |
Forward PE | 20.13 | 20.77 | 27.99 | 25.66 | 34.30 | 57.14 |
P/FCF Ratio | 9.78 | 21.65 | 38.80 | 39.99 | 66.10 | 44.66 |
PS Ratio | 1.22 | 1.66 | 3.01 | 3.55 | 5.05 | 9.02 |